Compensation award — excluded from discretionary-purchase analysis.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Officer sold ~$83K of PFE shares in the open market
Traded Aug 5, 2026 · Filed Aug 6, 2026
- ~$83K
- Reported value · 3,278 sh @ $25.40
- 29K
- Holds after · shares reported
- +8.9%
- stock since the trade · S&P 500 -0.8%, $25.81 → $28.12 on Oct 1
Why it stands out
No pre-arranged plan is mentioned in the filing
- No pre-arranged plan is mentioned in the filing
- Sold 10% of their holdings
- Insiders also bought $1.96M of Pfizer stock in the past 3 months
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 5, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 6, 2026
Officer$25K–$100K
Context
- Classification
open market sale
Code S — open-market or private sale
- Absolute commitment
~$83,261
Shares × reported transaction price
- Timing vs results
1 day after results of Aug 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
- Price at the time
Closed at $25.81 on Aug 5, 2026, 9% above its 52-week low and 10% below its high, after a 4% rise over the previous 30 trading days